(Q48633444)

13 February 2018

title

Proliferation- and apoptosis-related proteins in intracranial ependymomas: an immunohistochemical analysis. (English)

1 reference

13 February 2018

1 reference

M J T Verstegen

1

1 reference

13 February 2018

D Troost S Leenstra

series ordinal

2

1 reference

13 February 2018

H Ijlst-Keizers

series ordinal

3

1 reference

13 February 2018

D A Bosch

series ordinal

4

1 reference

13 February 2018

publication date

1 January 2002

1 reference

13 February 2018

Journal of Neuro-Oncology

published in

1 reference

13 February 2018

volume

56

1 reference

13 February 2018

issue

1

1 reference

13 February 2018

page(s)

21-28

1 reference

13 February 2018

https://scigraph.springernature.com/pub.10.1023/a:1014471714058

exact match

0 references

cites work

Ependymoma: a follow-up study of 101 cases

1 reference

12 December 2020

Bcl-2 distribution in neuroepithelial tumors: an immunohistochemical study.

1 reference

12 December 2020

The new WHO classification of brain tumours

1 reference

12 December 2020

Ependymoma: internal correlations among pathological signs: the anaplastic variant

1 reference

12 December 2020

Chromosome arm 6q loss is the most common recurrent autosomal alteration detected in primary pediatric ependymoma

1 reference

12 December 2020

Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt's lymphoma cells.

1 reference

12 December 2020

Apoptosis and cell proliferation in human neuroepithelial tumors.

1 reference

12 December 2020

Cytogenetic analysis of 109 pediatric central nervous system tumors.

1 reference

12 December 2020

Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line.

1 reference

12 December 2020

Intracranial ependymoma: long-term results of a policy of surgery and radiotherapy

1 reference

12 December 2020

p53 Mutation and MDM2 amplification in human soft tissue sarcomas

1 reference

12 December 2020

MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor

1 reference

12 December 2020

No evidence for functional inactivation of wild-type p53 protein by MDM2 overexpression in gastric carcinogenesis.

1 reference

12 December 2020

mdm2 gene alterations and mdm2 protein expression in breast carcinomas

1 reference

12 December 2020

Infrequency of p53 gene mutations in ependymomas

1 reference

12 December 2020

Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo

1 reference

12 December 2020

Prognostic factors in intracranial ependymomas in children.

1 reference

12 December 2020

Ependymomas: MIB-1 proliferation index and survival

1 reference

12 December 2020

Lack of histopathological correlation of malignant ependymomas with postoperative survival

1 reference

12 December 2020

Amplification and overexpression of MDM2 in primary (de novo) glioblastomas.

1 reference

12 December 2020

The p53 tumor-suppressor gene

1 reference

12 December 2020

Human gliomas with wild-type p53 express bcl-2.

1 reference

12 December 2020

Point mutations and nucleotide insertions in the MDM2 zinc finger structure of human tumours

1 reference

12 December 2020

Proliferating cell nuclear antigen expression in brain tumors, and its prognostic role in ependymomas: an immunohistochemical study.

1 reference

12 December 2020

Treatment of ependymomas. Clinical and non-clinical factors influencing prognosis: a review

1 reference

12 December 2020

Ki-67 immunolabelling index is a prognostic indicator in childhood posterior fossa ependymomas.

1 reference

12 December 2020

Ependymomas: clinical and pathological aspects.

1 reference

12 December 2020

Coexpression of genes involved in apoptosis in central nervous system neoplasms.

1 reference

12 December 2020

Mdm2 promotes the rapid degradation of p53

1 reference

12 December 2020

Rare occurrence of inactivating p53 gene mutations in primary non-astrocytic tumors of the central nervous system: reappraisal by yeast functional assay

1 reference

12 December 2020

Involvement of chromosome 22 in ependymomas.

1 reference

12 December 2020

An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms

1 reference

12 December 2020

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

1 reference

12 December 2020

Disseminated ependymomas of the central nervous system

1 reference

12 December 2020

Chromosomes in the genesis and progression of ependymomas.

1 reference

12 December 2020

Cyclin D1 and MIB-1 immunohistochemistry in ependymomas: a study of 41 cases.

1 reference

12 December 2020

The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining.

1 reference

12 December 2020

Molecular cytogenetic studies of pediatric ependymomas

1 reference

12 December 2020

Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer.

1 reference

12 December 2020

Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype.

1 reference

12 December 2020

Short alternative splice transcripts of the mdm2 oncogene correlate to malignancy in human astrocytic neoplasms.

1 reference

12 December 2020

Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group

1 reference

12 December 2020

Improved survival of patients with intracranial ependymomas by irradiation: Dose selection and field extension

1 reference

12 December 2020

Double identity for proteins of the Bcl-2 family

1 reference

12 December 2020

Ependymomas. A clinical survey.

1 reference

12 December 2020

Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line

1 reference

12 December 2020

The prognostic significance of postoperative residual tumor in ependymoma

1 reference

12 December 2020

Enhanced translation: a novel mechanism of mdm2 oncogene overexpression identified in human tumor cells

1 reference

12 December 2020

The molecular biology of ependymomas

1 reference

12 December 2020

Ki-67 immunoreactivity in human central nervous system tumors: a study with MIB 1 monoclonal antibody on archival material

1 reference

12 December 2020

The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics

1 reference

12 December 2020

Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas

1 reference

12 December 2020

Molecular analysis of genetic changes in ependymomas.

1 reference

12 December 2020

Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax:Bcl-2 ratio.

1 reference

12 December 2020

Infratentorial ependymomas in childhood: prognostic factors and treatment.

1 reference

12 December 2020

Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations.

1 reference

12 December 2020

Ependymal neoplasms in children

1 reference

12 December 2020

Histologic prognostic factors in ependymoma

1 reference

12 December 2020

The growth potential of ependymomas with varying grades of malignancy measured by the Ki-67 labelling index and mitotic index.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1014471714058

1 reference

13 February 2018

Dimensions Publication ID

1021033068

0 references

1 reference

13 February 2018